ARDS Outcomes Better With Intravenous vs Inhaled Sedative

[ad_1]

(MedPage Today) — For patients with moderate to severe acute respiratory distress syndrome (ARDS), prolonged sedation with the inhaled volatile agent sevoflurane resulted in worse outcomes than intravenous propofol, the randomized SESAR trial…

[ad_2]

Source link : https://www.medpagetoday.com/pulmonology/generalpulmonary/114727

Author :

Publish date : 2025-03-19 14:31:00

Copyright for syndicated content belongs to the linked Source.